journal
Journals Australian & New Zealand Journ...

Australian & New Zealand Journal of Obstetrics & Gynaecology

https://read.qxmd.com/read/38634663/obstetrician-views-on-fetal-pillow%C3%A2-device-use-and-research-in-aotearoa-new-zealand-a-cross-sectional-survey
#1
JOURNAL ARTICLE
Lynn Sadler, Robin Cronin, Erena Browne, Amanda Harvey, Meghan G Hill
BACKGROUND: There is anecdotal evidence of Fetal Pillow® use, but no formal local information on clinician practices and perspectives. AIMS: To assess obstetrician use of the Fetal Pillow®, knowledge of relevant research, and interest in a proposed randomised controlled trial in Aotearoa New Zealand. MATERIALS AND METHODS: Anonymous cross-sectional survey of practising obstetricians and obstetric trainees in Aotearoa New Zealand distributed by the Royal Australian and New Zealand College of Obstetricians and Gynaecologists...
April 18, 2024: Australian & New Zealand Journal of Obstetrics & Gynaecology
https://read.qxmd.com/read/38634525/the-first-international-association-of-diabetes-and-pregnancy-study-groups-summit-on-the-diagnosis-of-gestational-diabetes-in-early-pregnancy-tobogm-summit-report
#2
JOURNAL ARTICLE
Arianne Sweeting, Freya MacMillan, David Simmons
The first International Association of Diabetes and Pregnancy Study Groups Summit on the diagnosis of gestational diabetes in early pregnancy (Treatment of Booking Gestational Diabetes Mellitus (TOBOGM) Summit) was held on the 17 November 2022 in Sydney, Australia. It sought to use the TOBOGM trial findings to scope the issues involved with early screening, to inform future discussions over possible approaches for diagnosing gestational diabetes mellitus (GDM) in early pregnancy. Most delegates supported testing for early GDM using a one-step 75 g oral glucose tolerance test approach with Canadian Diabetes Association criteria preferred, but highlighted the importance of considering resources, cost, consumer perspectives and equity in translating TOBOGM results into a clinical approach to screening for, and diagnosing, early GDM...
April 18, 2024: Australian & New Zealand Journal of Obstetrics & Gynaecology
https://read.qxmd.com/read/38632883/percutaneous-tibial-nerve-stimulation-for-the-overactive-bladder-a-single-arm-trial
#3
JOURNAL ARTICLE
Hnin Yee Kyaw, Hannah G Krause, Judith T W Goh
AIMS: We hypothesise that PTNS is a safe and effective treatment for OAB. Overactive bladder (OAB) is estimated to affect 11.8% of women worldwide, causing diminished quality of life. Lifestyle modifications, muscarinic receptor antagonist and beta-adrenoreceptor agonist remain the mainstay of treatment but are limited by their efficacy and adverse effects. Access to third-line therapies of intravesical botulinum toxin type A or sacral neuromodulation is limited by their invasive nature...
April 17, 2024: Australian & New Zealand Journal of Obstetrics & Gynaecology
https://read.qxmd.com/read/38629771/authors-response-to-letter-to-the-editor-regarding-perinatal-outcomes-after-regional-analgesia-during-labour
#4
LETTER
Janna Lawson, Roshan Selvaratnam
No abstract text is available yet for this article.
April 17, 2024: Australian & New Zealand Journal of Obstetrics & Gynaecology
https://read.qxmd.com/read/38629765/reply-to-perinatal-outcomes-after-regional-analgesia-during-labour
#5
LETTER
Kara Thompson, Nisha Khot
No abstract text is available yet for this article.
April 17, 2024: Australian & New Zealand Journal of Obstetrics & Gynaecology
https://read.qxmd.com/read/38597287/editor-in-chief-s-introduction-to-anzjog-64-2
#6
EDITORIAL
Scott W White
No abstract text is available yet for this article.
April 10, 2024: Australian & New Zealand Journal of Obstetrics & Gynaecology
https://read.qxmd.com/read/38581105/improvements-from-a-small-group-multidisciplinary-pain-self-management-intervention-for-women-living-with-pelvic-pain-maintained-at-12%C3%A2-months
#7
JOURNAL ARTICLE
Karen Joseph, Jessica Mills
BACKGROUND: A small-group multidisciplinary pain self-management program for women living with pelvic pain, with or without endometriosis, was developed to address identified unmet treatment needs. Following completion, over 80% of participants demonstrated clinically significant improvement across a number of domains. There was no clinically significant deterioration on any measure and benefits continued at three months follow-up. AIMS: This study examines patient-reported outcomes at 12 months following program completion to ascertain maintenance of these improvements...
April 5, 2024: Australian & New Zealand Journal of Obstetrics & Gynaecology
https://read.qxmd.com/read/38577897/extending-the-new-era-of-genomic-testing-into-pregnancy-management-a-proposed-model-for-australian-prenatal-services
#8
JOURNAL ARTICLE
Alice Rogers, Lucas De Jong, Wendy Waters, Lesley H Rawlings, Keryn Simons, Song Gao, Julien Soubrier, Rosalie Kenyon, Ming Lin, Rob King, David M Lawrence, Peter Muller, Shannon Leblanc, Lesley McGregor, Suzanne C E H Sallevelt, Jan Liebelt, Tristan S E Hardy, Janice M Fletcher, Hamish S Scott, Abhi Kulkarni, Christopher P Barnett, Karin S Kassahn
BACKGROUND: Trio exome sequencing can be used to investigate congenital abnormalities identified on pregnancy ultrasound, but its use in an Australian context has not been assessed. AIMS: Assess clinical outcomes and changes in management after expedited genomic testing in the prenatal period to guide the development of a model for widespread implementation. MATERIALS AND METHODS: Forty-three prospective referrals for whole exome sequencing, including 40 trios (parents and pregnancy), two singletons and one duo were assessed in a tertiary hospital setting with access to a state-wide pathology laboratory...
April 5, 2024: Australian & New Zealand Journal of Obstetrics & Gynaecology
https://read.qxmd.com/read/38571447/outpatient-hysteroscopy-suitable-for-all-a-retrospective-cohort-study-of-safety-success-and-acceptability-in-australia
#9
JOURNAL ARTICLE
Rebecca Nash, Samir Saidi
BACKGROUND: In Australia, gynaecologists continue to assess and investigate abnormal uterine bleeding with inpatient hysteroscopy despite evidence validating outpatient hysteroscopy services. AIM: This retrospective cohort study assessed the safety, success and acceptability of office hysteroscopy in a gynae-oncology rapid-access clinic over six years in Sydney, Australia, and included all women without an age or body mass index (BMI) cut-off using a 'see and treat' concept...
April 4, 2024: Australian & New Zealand Journal of Obstetrics & Gynaecology
https://read.qxmd.com/read/38566470/covid-19-lockdowns-affected-birthing-outcomes-in-a-regional-new-south-wales-health-district
#10
JOURNAL ARTICLE
Pierre Hofstee, Bridie Mulholland, Megan Kelly, Warren Davis, Kate Curtis
INTRODUCTION: The 400 000 residents of the Illawarra Shoalhaven Local Health District (ISLHD) experienced two distinct lockdowns aimed at mitigating the transmission of severe acute respiratory syndrome coronavirus 2 infection. Analysing effects of these lockdowns on maternal and neonatal outcomes presents a valuable opportunity to assess the impact of pandemic-level restrictions on maternal and neonatal outcomes. AIM: Evaluate the impacts of restrictions from two lockdown periods on maternal, birthing, and neonatal outcomes within a regional local health district...
April 2, 2024: Australian & New Zealand Journal of Obstetrics & Gynaecology
https://read.qxmd.com/read/38549233/a-study-protocol-for-live-and-deceased-donor-uterus-transplantation-as-a-treatment-for-women-with-uterine-factor-infertility
#11
JOURNAL ARTICLE
Jana Pittman, Mats Brännström, Neill Keily, Brigitte Gerstl, Elena Cavazzoni, Henry Pleass, Mianna Lotz, Natasha Rogers, Germaine Wong, Wayne Hsueh, Ashraf Hanafy, Jason A Abbott, Rebecca Deans
AIM: Uterus transplantation (UTx) is an emerging treatment option for women with uterine factor infertility (UFI) or the absence of a functional uterus. This is the study protocol for the first human UTx clinical trial in Australia. MATERIALS AND METHODS: This protocol outlines the approved training program used to plan, diagnose, screen, and treat patients who may be eligible for UTx using living and deceased donors. This multi-site clinical research study includes three tertiary hospital sites within New South Wales (NSW), Australia - Prince of Wales, Royal Hospital for Women and Westmead Hospitals...
March 28, 2024: Australian & New Zealand Journal of Obstetrics & Gynaecology
https://read.qxmd.com/read/38549222/severe-maternal-morbidity-we-need-more-action-to-prevent-harm
#12
EDITORIAL
Evelyn Jane MacDonald, Beverley Lawton, Francesca Storey, Kendall Stevenson, John David Tait, Peter Stone
No abstract text is available yet for this article.
March 28, 2024: Australian & New Zealand Journal of Obstetrics & Gynaecology
https://read.qxmd.com/read/38514899/health-needs-treatment-decisions-and-experience-of-traditional-complementary-and-integrative-medicine-use-by-women-with-diminished-ovarian-reserve-a%C3%A2-cross-sectional-survey
#13
JOURNAL ARTICLE
Alison Maunder, Susan Arentz, Mike Armour, Michael F Costello, Carolyn Ee
BACKGROUND: Women with diminished ovarian reserve (DOR) have fewer eggs than would be expected at their age. It is estimated that 10% of women seeking fertility treatment are diagnosed with DOR. However, the success rate of medically assisted reproduction (MAR) is significantly lower in women with DOR, thus many seek additional approaches. AIM: To explore the health needs of women with DOR, treatment options and experience of treatment including traditional complementary integrative medicine (TCIM)...
March 21, 2024: Australian & New Zealand Journal of Obstetrics & Gynaecology
https://read.qxmd.com/read/38425311/colposcopy-performance-in-the-new-primary-hpv-screening-in-australia-how-to-determine-colposcopy-competency
#14
JOURNAL ARTICLE
Jeffrey H J Tan, Deborah Neesham, Rebecca A Szabo, Natalia Khomko, Desiree Yap, C David H Wrede
AIMS: To assess colposcopic performance and determine indicators for competency within the new Australian primary human papillomavirus (HPV) cervical screening program. MATERIALS AND METHODS: A retrospective observational study of 4542 women seen at The Royal Women's Hospital Colposcopy Clinic in Melbourne, from 1 December 2017 to 31 July 2020 after a higher-risk cervical screening test (CST) result. RESULTS: Histological CIN2+ was detected in 25...
March 1, 2024: Australian & New Zealand Journal of Obstetrics & Gynaecology
https://read.qxmd.com/read/38425188/-i-was-able-to-make-a-better-decision-about-my-health-w%C3%A4-hine-experiences-of-colposcopy-at-a-marae-based-health-clinic-a-qualitative-study
#15
JOURNAL ARTICLE
Judy Ormandy, Simon Phillips, Maringikura Campbell, Bernie Haenga-Melvin, Luana Phillips-Govind, Sara Filoche
BACKGROUND: Equitable access to colposcopy services is required if we are to realise the benefit of the introduction of human papilloma virus (HPV) screening in Aotearoa New Zealand. We piloted a community colposcopy clinic, co-located at an urban marae health clinic. AIM: To describe the experiences of wāhine (women) attending the marae-based colposcopy clinic. METHODS: An in-depth reflexive thematic analysis from 34 people's accounts was undertaken...
February 29, 2024: Australian & New Zealand Journal of Obstetrics & Gynaecology
https://read.qxmd.com/read/38425177/efficacy-and-feasibility-of-the-rada16-self-assembling-peptide-purastat%C3%A2-for-haemostasis-in-laparoscopic-gynaecological-surgery-a-pilot-study
#16
JOURNAL ARTICLE
Philip Hall
Bleeding after laparoscopic gynaecological surgery remains a potential complication. We assessed RADA16 (PuraStat®), a topical self-assembling peptide haemostatic agent, in a pilot study of 46 women undergoing laparoscopic gynaecological surgery. The primary outcome was intraoperative haemostatic efficacy for resection site bleeding. Haemostasis was achieved in all intraoperative bleeding situations (40/40 participants: 100%) with no clinically significant surgical bed bleeding or complications. Mean volume and time required to achieve haemostasis were 6 mL and 14 sec, respectively...
February 29, 2024: Australian & New Zealand Journal of Obstetrics & Gynaecology
https://read.qxmd.com/read/38415783/a-survey-of-cost-access-and-outcomes-for-cannabinoid-based-medicinal-product-use-by-australians-with-endometriosis
#17
JOURNAL ARTICLE
Andrew Proudfoot, Sarah Duffy, Justin Sinclair, Jason Abbott, Mike Armour
People with endometriosis use cannabis to manage their symptoms. This study aimed to identify costs, modes of administration, product composition, and self-reported effectiveness for those accessing medicinal cannabis in Australia. There were 192 survey responses analysed. Most (63.5%) used a 'cannabis clinic' doctor, incurring an initial consultation cost of $100-$200+ (10.2% Medicare bulk-billed) and median cannabinoid medicine costs of $300AUD per month. Cost was a major barrier to access, necessitating reducing dosage (76...
February 28, 2024: Australian & New Zealand Journal of Obstetrics & Gynaecology
https://read.qxmd.com/read/38415771/conventional-in-vitro-fertilisation-rather-than-intracytoplasmic-sperm-injection-when-only-one-oocyte-is-retrieved-time-to-overcome-irrational-fears
#18
JOURNAL ARTICLE
Valerio Pisaturo, Marco Reschini, Cristina Guarneri, Elena Sanzani, Alessio Paffoni, Edgardo Somigliana
BACKGROUND: The use of intracytoplasmic sperm injection (ICSI) currently extends beyond male factor infertility, notably replacing conventional in vitro fertilisation (IVF) in scenarios like limited oocyte availability, where it is used as a precaution against complete fertilisation failure. While existing studies on the use of conventional IVF in such situations provide some reassurance, the available evidence is somewhat insufficient and ICSI is commonly used. AIMS: To evaluate whether conventional IVF can be a feasible option when only one oocyte is retrieved...
February 28, 2024: Australian & New Zealand Journal of Obstetrics & Gynaecology
https://read.qxmd.com/read/38380539/clinical-utility-of-maternal-torch-screening-in-fetal-growth-restriction-a-retrospective-two-centre-study
#19
JOURNAL ARTICLE
Christine A Wade, Naomi Atkinson, Natasha E Holmes, Lisa Hui
OBJECTIVE: The aim of this study was to evaluate the indications for maternal TORCH (Toxoplasma gondii, rubella, cytomegalovirus (CMV), and herpes simplex virus (HSV)) serology, with a focus on the yield in isolated fetal growth restriction (FGR). MATERIALS AND METHODS: A retrospective review of antenatal TORCH testing between January 2014 and December 2018 was carried out at two hospitals in Melbourne, Australia. TORCH testing ordered for pregnancy losses and stillbirth was excluded...
February 21, 2024: Australian & New Zealand Journal of Obstetrics & Gynaecology
https://read.qxmd.com/read/38366682/a-step-closer-to-parenthood-with-non-obstructive-azoospermia-unveiling-the-impact-of-microdissection-testicular-sperm-extraction-in-australia-s-largest-single-centre-study
#20
JOURNAL ARTICLE
Hossam Elzeiny, Franca Agresta, John Stevens, David K Gardner
BACKGROUND: Non-obstructive azoospermia (NOA) diagnosis poses challenges for couples seeking parenthood. Microdissection testicular sperm extraction (MD-TESE) excels in retrieving testicular sperm cells for NOA cases. However, limited live birth data in Australian NOA patients hinders accurate counselling. AIMS: This study aimed to determine the likelihood of infertile couples with a male partner diagnosed with NOA conceiving biological children using MD-TESE / intracytoplasmic sperm injection (ICSI)...
February 17, 2024: Australian & New Zealand Journal of Obstetrics & Gynaecology
journal
journal
21013
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.